Search - tctmd.com

Displaying 61 - 80 of 138

Sort: Relevancy | Date

News Daily News

Study Suggests Immature Platelet Count Predicts MACE Risk in CAD

November 17, 2014

News Daily News

SORT OUT III Substudy Hints at Differences in DES Efficacy Based on Diabetes Status

Todd Neale

November 17, 2014

News Daily News

Acute Hyperglycemia Worsens Post-AMI Prognosis

October 24, 2014

Presentation VEINS 2014

Targeting Inflammation in CVI: The Role of Pharmacotherapy

Presenter: John R. Bartholomew

October 11, 2014

News Conference News TCT 2014

Bioabsorbable Polymer DES Represent Evolution to Stenting Platform

September 19, 2014

Presentation TCT 2014

Comparison of endothelialization and inflammation between thin- and thick-strut contemporary bioerodable polymer drug-eluting stents and thick-strut fully resorbable scaffolds i___

Presenter: Kazuyuki Yahagi

September 16, 2014

News Conference News TCT 2014

Experts Consider Role of Statins in Prevention of Contrast-Induced Nephropathy

September 16, 2014

News Conference News TCT 2014

Keynote Address Focuses on Newer DES, Problematic Subgroups

September 15, 2014

News Industry News

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

September 10, 2014

News Conference News ESC 2014

IBIS-4: High-Dose Statin Therapy May Reverse Atherosclerosis in STEMI

Todd Neale

September 02, 2014

News Industry News

GSK announces start of phase III cardiovascular outcomes study with losmapimod in patients with acute coronary syndrome

June 05, 2014

News Daily News

PROSPECT Substudy: Persistently High CRP Predicts Future MACE in ACS Patients After PCI

June 04, 2014

News Conference News ACC 2014

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

Yael L. Maxwell

April 03, 2014

News Industry News

Boston Scientific Announces Schedule for Presentations at American College of Cardiology 2014

March 27, 2014

News Daily News

DES Outcomes Vary by Diabetes Status, Lesion Complexity

Caitlin E. Cox

March 13, 2014

News Conference News Cell Therapy 2014

Repeat Cell Therapy for Chronic Heart Failure Being Tested in Randomized Trials

January 26, 2014

News Conference News AHA 2013

Varying Cell Therapy Techniques Demonstrate Safety, Mixed Efficacy at AHA 2013

November 17, 2013

News Daily News

HORIZONS-AMI: Mortality Reduction with Bivalirudin Only Partially Due to Bleeding

Caitlin E. Cox

November 01, 2013

News Conference News TCT 2013

ABSORB III and IV Trials Aim to Prove Superiority of BVS

October 28, 2013

News Daily News

Case Series Shows Learning Curve of Controversial MS Angioplasty Procedure

L.A. McKeown

August 30, 2013

Advertisement

Study Suggests Immature Platelet Count Predicts MACE Risk in CAD

SORT OUT III Substudy Hints at Differences in DES Efficacy Based on Diabetes Status

Acute Hyperglycemia Worsens Post-AMI Prognosis

Targeting Inflammation in CVI: The Role of Pharmacotherapy

Bioabsorbable Polymer DES Represent Evolution to Stenting Platform

Comparison of endothelialization and inflammation between thin- and thick-strut contemporary bioerodable polymer drug-eluting stents and thick-strut fully resorbable scaffolds i___

Experts Consider Role of Statins in Prevention of Contrast-Induced Nephropathy

Keynote Address Focuses on Newer DES, Problematic Subgroups

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

IBIS-4: High-Dose Statin Therapy May Reverse Atherosclerosis in STEMI

GSK announces start of phase III cardiovascular outcomes study with losmapimod in patients with acute coronary syndrome

PROSPECT Substudy: Persistently High CRP Predicts Future MACE in ACS Patients After PCI

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

Boston Scientific Announces Schedule for Presentations at American College of Cardiology 2014

DES Outcomes Vary by Diabetes Status, Lesion Complexity

Repeat Cell Therapy for Chronic Heart Failure Being Tested in Randomized Trials

Varying Cell Therapy Techniques Demonstrate Safety, Mixed Efficacy at AHA 2013

HORIZONS-AMI: Mortality Reduction with Bivalirudin Only Partially Due to Bleeding

ABSORB III and IV Trials Aim to Prove Superiority of BVS

Case Series Shows Learning Curve of Controversial MS Angioplasty Procedure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content